Apply to trial NCT06522334

A few quick questions so the study team can decide if you might be a fit.

Recruiting

Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death. There are no additional interventions regarding this registry.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening